Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stauffer

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Pediatrics|July 9, 2015
Live Video Diet and Exercise Intervention in Overweight and Obese Youth: Adherence and Cardiovascular HealthSusan E Nourse, Inger Olson, Rita A Popat, et al.
Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.
Pediatric Transplantation|November 6, 2018
Healthy hearts in pediatric heart transplant patients with an exercise and diet intervention via live video conferencing-Design and rationaleAngela C Chen, David N Rosenthal, Sarah C Couch, et al.
Journal of the American Heart Association|January 25, 2020
Healthy Hearts via Live Videoconferencing: An Exercise and Diet Intervention in Pediatric Heart Transplant RecipientsAngela C Chen, Faustine D Ramirez, David N Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|February 17, 1998
Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460): coapplication of structure-based design and rapid multiple analogue synthesis on solid supportS F Brady, K J Stauffer, W C Lumma, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Journal of Medicinal Chemistry|April 2, 2005
9-hydroxyazafluorenes and their use in thrombin inhibitorsKenneth J Stauffer, Peter D Williams, Harold G Selnick, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Pediatrics|July 9, 2015
Live Video Diet and Exercise Intervention in Overweight and Obese Youth: Adherence and Cardiovascular HealthSusan E Nourse, Inger Olson, Rita A Popat, et al.
Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.
Pediatric Transplantation|November 6, 2018
Healthy hearts in pediatric heart transplant patients with an exercise and diet intervention via live video conferencing-Design and rationaleAngela C Chen, David N Rosenthal, Sarah C Couch, et al.
Journal of the American Heart Association|January 25, 2020
Healthy Hearts via Live Videoconferencing: An Exercise and Diet Intervention in Pediatric Heart Transplant RecipientsAngela C Chen, Faustine D Ramirez, David N Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|February 17, 1998
Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460): coapplication of structure-based design and rapid multiple analogue synthesis on solid supportS F Brady, K J Stauffer, W C Lumma, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Journal of Medicinal Chemistry|April 2, 2005
9-hydroxyazafluorenes and their use in thrombin inhibitorsKenneth J Stauffer, Peter D Williams, Harold G Selnick, et al.
Pageof 5